Danaher Co. (NYSE:DHR) Stock Position Trimmed by Dorsey & Whitney Trust CO LLC

Dorsey & Whitney Trust CO LLC decreased its position in Danaher Co. (NYSE:DHR) by 9.7% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 10,460 shares of the conglomerate’s stock after selling 1,118 shares during the period. Dorsey & Whitney Trust CO LLC’s holdings in Danaher were worth $2,612,000 as of its most recent SEC filing.

Other large investors also recently made changes to their positions in the company. Cary Street Partners Investment Advisory LLC raised its stake in Danaher by 20.2% during the 4th quarter. Cary Street Partners Investment Advisory LLC now owns 9,128 shares of the conglomerate’s stock valued at $2,112,000 after acquiring an additional 1,533 shares in the last quarter. First Citizens Bank & Trust Co. raised its stake in shares of Danaher by 0.6% during the fourth quarter. First Citizens Bank & Trust Co. now owns 26,611 shares of the conglomerate’s stock valued at $6,156,000 after purchasing an additional 149 shares in the last quarter. Cercano Management LLC lifted its holdings in Danaher by 11.4% in the fourth quarter. Cercano Management LLC now owns 202,569 shares of the conglomerate’s stock worth $46,862,000 after purchasing an additional 20,715 shares during the period. Allspring Global Investments Holdings LLC increased its stake in Danaher by 48.1% during the 4th quarter. Allspring Global Investments Holdings LLC now owns 296,996 shares of the conglomerate’s stock valued at $68,707,000 after buying an additional 96,395 shares during the period. Finally, Donaldson Capital Management LLC increased its stake in Danaher by 5.8% during the 1st quarter. Donaldson Capital Management LLC now owns 1,469 shares of the conglomerate’s stock valued at $367,000 after buying an additional 80 shares during the period. Institutional investors and hedge funds own 79.05% of the company’s stock.

Analyst Upgrades and Downgrades

DHR has been the subject of several recent analyst reports. Barclays increased their price objective on shares of Danaher from $260.00 to $270.00 and gave the company an “equal weight” rating in a report on Wednesday, April 24th. Evercore ISI cut their price target on shares of Danaher from $266.00 to $260.00 and set an “outperform” rating for the company in a report on Tuesday, July 2nd. Robert W. Baird lifted their price objective on shares of Danaher from $259.00 to $271.00 and gave the stock an “outperform” rating in a research note on Wednesday, April 24th. TD Cowen increased their target price on shares of Danaher from $280.00 to $290.00 and gave the company a “buy” rating in a research note on Wednesday, April 24th. Finally, HSBC upgraded shares of Danaher from a “hold” rating to a “buy” rating and lifted their price target for the stock from $250.00 to $280.00 in a research report on Wednesday, April 17th. Six equities research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. According to data from MarketBeat, Danaher has an average rating of “Moderate Buy” and an average target price of $268.67.

Danaher Stock Down 0.5 %

DHR traded down $1.24 on Friday, reaching $243.55. 2,982,291 shares of the company traded hands, compared to its average volume of 2,867,454. The company has a market cap of $180.39 billion, a price-to-earnings ratio of 41.28, a PEG ratio of 3.84 and a beta of 0.83. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.85 and a quick ratio of 1.51. The stock’s 50 day moving average price is $254.76 and its 200-day moving average price is $247.96. Danaher Co. has a 52-week low of $182.09 and a 52-week high of $269.11.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Tuesday, April 23rd. The conglomerate reported $1.92 earnings per share for the quarter, topping analysts’ consensus estimates of $1.72 by $0.20. The business had revenue of $5.80 billion for the quarter, compared to the consensus estimate of $5.62 billion. Danaher had a net margin of 16.78% and a return on equity of 11.43%. Danaher’s revenue for the quarter was down 2.6% compared to the same quarter last year. During the same period in the prior year, the business posted $2.36 earnings per share. On average, sell-side analysts expect that Danaher Co. will post 7.63 EPS for the current fiscal year.

Danaher Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, July 26th. Investors of record on Friday, June 28th will be paid a $0.27 dividend. The ex-dividend date is Friday, June 28th. This represents a $1.08 annualized dividend and a dividend yield of 0.44%. Danaher’s payout ratio is 18.31%.

Insider Buying and Selling

In other Danaher news, SVP Brian W. Ellis sold 4,000 shares of Danaher stock in a transaction that occurred on Wednesday, April 24th. The shares were sold at an average price of $250.01, for a total value of $1,000,040.00. Following the completion of the sale, the senior vice president now directly owns 29,830 shares in the company, valued at $7,457,798.30. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In related news, SVP Brian W. Ellis sold 4,000 shares of the firm’s stock in a transaction that occurred on Wednesday, April 24th. The stock was sold at an average price of $250.01, for a total value of $1,000,040.00. Following the transaction, the senior vice president now directly owns 29,830 shares of the company’s stock, valued at approximately $7,457,798.30. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Rainer Blair sold 9,005 shares of the company’s stock in a transaction that occurred on Thursday, May 16th. The stock was sold at an average price of $265.00, for a total value of $2,386,325.00. Following the sale, the chief executive officer now directly owns 106,990 shares of the company’s stock, valued at approximately $28,352,350. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 148,783 shares of company stock worth $37,536,717. Insiders own 11.10% of the company’s stock.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.